I am optimistic that GeNose would be standardized to allow members of society at large to get it quickly
Jakarta – The University of Gadjah Mada’s (UGM’s) GeNose C-19 that can function as an alternative COVID-19 screening tool must be produced on a massive scale to broaden its outreach in Indonesia, a legislator stated here, Thursday.
” I am optimistic that GeNose would be standardized to allow members of society at large to acquire it easily,” Elva Hartati, a member of the House of Representatives’ (DPR’s) Commission IX Overseeing Health and Labor force Affairs, affirmed.
The mass production of GeNose will enhance Indonesia’s early detection capability, she remarked, including that the level of accuracy for screening the novel coronavirus illness (COVID-19) is claimed to reach 90 percent.
Moreover, the asking price of the UGM’s group of scientists’ ingenious item that has actually received the Indonesian Ministry of Health’s distribution license given that December 2020 is also much lower than that of the antigen test, she stated.
According to the university’s main website that ANTARA priced quote on Thursday, the soft launch of this COVID-19 breathalyzer testing tool was performed at the Tugu Train Station in Yogyakarta on February 3, 2021.
This Synthetic Intelligence-based testing tool that has the ability to identify “volatile organic substances through the human breath” (UGM, 2021) will likewise be utilized for travelers departing from the Pasar Senen Station, Central Jakarta.
In connection with this UGM’s GeNose C-19, Research Study and Technology Minister Bambang P. S. Brodjonegoro had stated earlier that it would not be a substitute to swab screening (polymerase domino effect (PCR) screening).
On Wednesday, Brodjonegoro and Transport Minister Budi Karya Sumadi had inspected the application of GeNose C19 installed at the Pasar Senen Train Station.
GeNose will be formally utilized for carrying out COVID-19 screening of train passengers from February 5 and will later on likewise be installed at airports.
The Indonesian government has been having a hard time to win the battle versus the international pandemic of COVID-19 considering that it announced the country’s very first verified cases on March 2, 2020.
The government has not just imposed the public activity restriction policy in the Java and Bali Islands since January 11, 2021, but likewise conducted a nationwide vaccination program that began on January 13, 2021.
Since January 26, 2021, Indonesia’s COVID-19 infection rate had actually gone beyond one million cases considering that President Widodo officially announced the nation’s very first COVID-19 cases on March 2,2020
Related news: GeNose for COVID-19 screening to not change PCR test: Minister
Related news: UGM’s COVID-19 breathalyzer test gets regulative approval
EDITED BY INE
